The Predictive Model for Risk of Chemotherapy-Induced Thrombocytopenia Based on Antineoplastic Drugs for Solid Tumors in Eastern China

The predictive model for risk of chemotherapy-induced thrombocytopenia based on antineoplastic drugs for solid tumors in eastern China

Chemotherapy-related thrombocytopenia (CIT) is a significant adverse event during chemotherapy, which can lead to reduced relative dose intensity, increased risk of serious bleeding and additional medical expenditure. Herein, we aimed to develop and validate a predictive nomogram model for prediction of CIT in patients with solid tumor. From Jun 1, 2018 to Sep 9, 2021, a total of 1541 patients who received 5750 cycles of chemotherapy were retros…

ASCO25: Amgen’s Nplate proves effective in GI cancer-linked thrombocytopaenia

Nplate improved platelet response and reduced therapy modification for patients with chemotherapy-induced thrombocytopaenia.The post ASCO25: Amgen’s Nplate proves effective in GI cancer-linked thrombocytopaenia appeared first on Clinical Trials Arena.

ASCO25: Amgen’s Nplate proves effective in GI cancer-linked thrombocytopaenia - Pharmaceutical Technology

Nplate improved platelet response and reduced therapy modification for patients with chemotherapy-induced thrombocytopaenia.